Oct 2022 $5 M No. 7 $2 to $10 million 1
RxFunction, Inc.: Raise no. 7, Oct 2022 × Investors in this round 1 investor had bought by the notice of Nov 10, 2022: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $10 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $500,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Minnesota People named in the notice Lars E. Oddsson · Executive Officer, Director Mary E. Anderson · Executive Officer, Director Kevin E. Roche · Director Richard E. Nigon · Director Richard E. Offerdahl · Director Robert E. Rinek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cedar Point Capital, LLC (CRD 145116) · broker-dealer Cedar Point Capital, LLC (CRD 145116) · Edina, Minnesota Sold in AZ, CA, CT, FL, IL, IN, MA, MN, MT, NC, ND, NJ, NY, OR, PA, TX, WI Remarks in the notice On fees: “Represents the maximum commission payable if entire offering is sold.”Signed by Mary E. Anderson, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 10, 2022. Read the notice at the SEC .
equity SEC Jan 2021 $4 M No. 6 $2 to $10 million 33
RxFunction, Inc.: Raise no. 6, Jan 2021 × Investors in this round 33 investors had bought by the notice of Jan 24, 2022: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $5 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them, other: The underlying offering is complete and this amendment to the original Form D covers only the Common Stock issuable upon exercise of warrants sold in the underlying offering. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $82,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Minnesota People named in the notice Joseph Daniel Leach · Executive Officer Lars E. Oddsson · Executive Officer, Director Mary E. Anderson · Executive Officer, Director Kevin Daniel Roche · Director Richard Daniel Nigon · Director Richard Daniel Offerdahl · Director Robert Daniel Rinek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cedar Point Capital, LLC (CRD 145116) · broker-dealer Cedar Point Capital, LLC (CRD 145116) · Edina, Minnesota Sold in AZ, CA, CT, FL, IL, IN, MA, MN, MT, NC, ND, NJ, NY, OR, PA, TX, WI Remarks in the notice On fees: “Reflects actual amount paid.”On the amounts: “The underlying offering is complete. The Total Remaining to be Sold reflects $649,470 of Common Stock that is issuable upon exercise of outstanding warrants.”Signed by Mary E. Anderson, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 24, 2022. Read the notice at the SEC .
options SEC Nov 2020 $4 M No. 5 $2 to $10 million 2
RxFunction, Inc.: Raise no. 5, Nov 2020 × Investors in this round 2 investors had bought by the notice of Mar 18, 2021: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $6 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them, other: The underlying offering is complete and this amendment to the original Form D covers only the Common Stock issuable upon exercise of warrants sold in the underlying offering. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Minnesota People named in the notice Joseph Daniel Leach · Executive Officer Lars E. Oddsson · Executive Officer, Director Mary E. Anderson · Executive Officer, Director Kevin H. Roche · Director Richard H. Offerdahl · Director Richard P. Nigon · Director Robert P. Rinek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The underlying offering is complete. The Total Remaining to be Sold reflects $2,000,000 of Common Stock that is issuable upon exercise of outstanding warrants.”Signed by Mary E. Anderson, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Mar 18, 2021. Read the notice at the SEC .
options SEC Mar 2020 $4 M No. 4 $2 to $10 million 41
RxFunction, Inc.: Raise no. 4, Mar 2020 × Investors in this round 41 investors had bought by the notice of Mar 16, 2021: 41 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them, other: The underlying offering is complete and this amendment to the original Form D covers only the Common Stock issuable upon exercise of warrants sold in the underlying offering. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $358,722
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Minnesota People named in the notice Joseph Daniel Leach · Executive Officer Lars E. Oddsson · Executive Officer, Director Mary E. Anderson · Executive Officer, Director Kevin Daniel Roche · Director Richard Daniel Nigon · Director Richard Daniel Offerdahl · Director Robert Daniel Rinek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cedar Point Capital, LLC (CRD 145116) · broker-dealer Cedar Point Capital, LLC (CRD 145116) · Edina, Minnesota Sold in AZ, CA, CT, FL, IL, IN, MA, MN, MT, NC, ND, NJ, NY, OR, PA, TX, WI Remarks in the notice On fees: “This amount represents the actual amount paid. The underlying offering is complete.”On the amounts: “The underlying offering is complete. The Total Remaining to be Sold reflects $275,978 of Common Stock that is issuable upon exercise of outstanding warrants.”Signed by Mary E. Anderson, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 16, 2021. Read the notice at the SEC .
options SEC Mar 2019 $4 M No. 3 $2 to $10 million 41
RxFunction, Inc.: Raise no. 3, Mar 2019 × Investors in this round 41 investors had bought by the notice of Oct 14, 2026: 41 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them, other: The underlying offering is complete and this amendment to the original Form D covers only the Common Stock issuable upon exercise of warrants sold in the underlying offerings. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $358,722
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Minnesota People named in the notice Lars Oddsson · Executive Officer, Director Mary E. Anderson · Executive Officer, Director Kevin Roche · Director Richard Nigon · Director Richard Offerdahl · Director Robert Rinek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cedar Point Capital, LLC (CRD 145116) · broker-dealer Cedar Point Capital, LLC (CRD 145116) · Edina, Minnesota Sold in AZ, CA, CT, FL, IL, IN, MA, MN, MT, NJ, NY, NC, ND, OR, PA, TX, WI Remarks in the notice On fees: “This amount represents the actual amount paid. The underlying offering is complete.”On the amounts: “The underlying offering is complete. The Total Remaining to be Sold reflects $275,978 of Common Stock that is issuable upon exercise of outstanding warrants issued in the offering as reported on Form D filed on 4/3/2019.”Signed by Mary E. Anderson, Chief Executive Officer. Source: SEC Form D and 6 amendments, newest notice filed Oct 14, 2026. Read the notice at the SEC .
options SEC Mar 2018 $2 M No. 2 $2 to $10 million 2
RxFunction, Inc.: Raise no. 2, Mar 2018 × Investors in this round 2 investors had bought by the notice of Mar 29, 2018: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $350,000
Finders' fees none
Paid to its own people $695,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions and payments to its own people as estimates
The company Corporation, incorporated in Minnesota People named in the notice Joseph D. Leach · Executive Officer, Director Lars Oddsson · Executive Officer, Director Mary E. Anderson · Executive Officer Thomas E. Morizio · Executive Officer, Director Kevin E. Roche · Director Richard E. Nigon · Director Robert E. Rinek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cedar Point Capital, LLC (CRD 145116) · broker-dealer Cedar Point Capital, LLC (CRD 145116) · Edina, Minnesota Sold in AL, CA, CT, FL, IL, IN, MA, MN, MT, NC, ND, NJ, NY, OR, PA, TX, WA, WI Remarks in the notice On fees: “This amount represents the maximum amount of commissions payable to Cedar Point assuming all of the shares are sold.”On the amounts: “Total amount sold does not include warrants to purchase up to 183,571 shares of Series A Preferred Stock at $0.56 per share issued in connection with the offering, which may never be exercised.”On the use of proceeds: “Estimate of officer salaries to be paid in 2018.”Signed by Mary E. Anderson, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 29, 2018. Read the notice at the SEC .
equity, options SEC Dec 2017 $8 M No. 1 $2 to $10 million 48
RxFunction, Inc.: Raise no. 1, Dec 2017 × Investors in this round 48 investors had bought by the notice of Oct 14, 2026: 48 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them, other: The underlying offerings are complete and this amendment to the original Form Ds covers only the Common Stock issuable upon exercise of warrants sold in the underlying offerings. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $769,038
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Minnesota People named in the notice Lars Oddsson · Executive Officer, Director Mary E. Anderson · Executive Officer, Director Kevin Roche · Director Richard Nigon · Director Richard Offerdahl · Director Robert Rinek · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cedar Point Capital, LLC (CRD 145116) · broker-dealer Cedar Point Capital, LLC (CRD 145116) · Edina, Minnesota Sold in AZ, CA, CT, FL, IL, IN, MA, MN, MT, NJ, NY, NC, ND, OR, PA, TX, WI Remarks in the notice On fees: “This amount represents the actual amount paid. The underlying offering is complete.”On the amounts: “The underlying offerings are complete. The Total Remaining to be Sold reflects $587,500 of Common Stock issuable upon exercise of warrants issued in the offering as reported on Form D filed 12/28/2017.”Signed by Mary E. Anderson, Chief Executive Officer. Source: SEC Form D and 4 amendments, newest notice filed Oct 14, 2026. Read the notice at the SEC .
options SEC